| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/22/2013 | US8357366 Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease |
| 01/22/2013 | US8357352 Aerosol suspension formulations containing TG 227 ea or TG 134 a as propellant |
| 01/22/2013 | CA2744515C Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-ii antagonist and/or a diuretic |
| 01/22/2013 | CA2689101C Modifying drug release in suspensions of ionic resin systems |
| 01/22/2013 | CA2685214C Improved controlled release oral dosage form |
| 01/22/2013 | CA2560595C Multi-vitamin and mineral nutritional supplements |
| 01/22/2013 | CA2560241C Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds |
| 01/22/2013 | CA2558783C Oral morphine multiparticulate formulation |
| 01/22/2013 | CA2557757C Medical device applications of nanostructured surfaces |
| 01/22/2013 | CA2537250C Topical preparations comprising a hydrophilic carrier and a silicone matrix |
| 01/22/2013 | CA2505298C Methods and compositions for applying pharmacologic agents to the ear |
| 01/22/2013 | CA2458794C Plasticized hydrophilic glasses for improved stabilization of biological agents |
| 01/22/2013 | CA2448607C Colloidal metal compositions and methods |
| 01/22/2013 | CA2441970C Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/22/2013 | CA2400610C Endoparasiticidal compositions comprising a cyclic depsipeptide |
| 01/22/2013 | CA2342732C Water-soluble concentrate obtained for an emulgator or water-solubilising phase and a complex of liquid lipophile substances of plant origin |
| 01/21/2013 | DE202012000910U1 Systemische Darreichungsformen mit kontrollierter Freisetzung und verbesserter Stabilität Systemic dosage forms with controlled release and improved stability |
| 01/20/2013 | CA2783106A1 Patch preparation |
| 01/19/2013 | WO2013012430A1 Dhea bioadhesive controlled release gel |
| 01/19/2013 | CA2795991A1 Dhea bioadhesive controlled release gel |
| 01/18/2013 | CA2746717A1 Anti-fungal diaper rash creme |
| 01/17/2013 | WO2013010137A2 A composition, device and method for delayed and sustained release of brain energy molecules |
| 01/17/2013 | WO2013010041A1 Formulations of amikacin and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis |
| 01/17/2013 | WO2013010032A1 Gel compositions of oxymetazoline and methods of use |
| 01/17/2013 | WO2013009761A1 Methods and apparatus for delivering a therapeutic agent to nasopharyngeal mucosa targets |
| 01/17/2013 | WO2013009701A2 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
| 01/17/2013 | WO2013009666A1 Compositions and methods for overcoming resistance to tramadol |
| 01/17/2013 | WO2013009607A1 Compressed gas aerosols with enhanced intensity and longevity of actives |
| 01/17/2013 | WO2013009378A1 Use of xanthophyll carotenoids to improve visual performance and neural efficiency |
| 01/17/2013 | WO2013009271A1 New improved dry powder formulation |
| 01/17/2013 | WO2013009253A1 Microfibrillated cellulose films for controlled release of active agents |
| 01/17/2013 | WO2013009186A1 Nicotinamide compositions and the therapeutic use thereof |
| 01/17/2013 | WO2013009142A2 Sustained/release pharmaceutical composition comripising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same |
| 01/17/2013 | WO2013009046A1 Method for manufacturing a patch |
| 01/17/2013 | WO2013009015A1 Novel production method for a composite powder comprising an ultraviolet blocker surface-treated layer |
| 01/17/2013 | WO2013009009A2 Film comprising poly octylcyanoacrylate for preventing tissue adhesion and method for manufacturing same |
| 01/17/2013 | WO2013008981A1 Spherical particles of clopidogrel bisulfate, pharmaceutical composition including same, and method for manufacturing same |
| 01/17/2013 | WO2013008909A1 Loxoprofen sodium-containing adhesive patch for external applications |
| 01/17/2013 | WO2013008716A1 Aqueous ophthalmic composition |
| 01/17/2013 | WO2013008715A1 Aqueous ophthalmic composition |
| 01/17/2013 | WO2013008714A1 Ophthalmic aqueous composition |
| 01/17/2013 | WO2013008594A1 Composition for preventing and treating garget |
| 01/17/2013 | WO2013008240A2 Liposomes co-encapsulating a bisphosphonate and an amphipathic agent |
| 01/17/2013 | WO2013008218A1 Stable dosage forms of arterolane and piperaquine |
| 01/17/2013 | WO2013008083A1 Pharmaceutical composition for enhancing anticancer efficacy of tamoxifen |
| 01/17/2013 | WO2013007792A1 Novel th2 polarizing compounds |
| 01/17/2013 | WO2013007698A1 Pharmaceutical composition for neurological disorders |
| 01/17/2013 | WO2013007584A1 Method for sterilising functionalised coated surfaces containing nucleotides and/or nucleotide derivatives |
| 01/17/2013 | WO2013007381A1 A new therapeutical composition containing apomorphine as active ingredient |
| 01/17/2013 | WO2013007365A1 Gel for use in a wound treatment composition |
| 01/17/2013 | WO2013007360A1 Controlled release pharmaceutical composition of non-ergoline dopamine agonist |
| 01/17/2013 | WO2013007092A1 Medicament for treatment of coronary heart diseases and angina pectoris and preparation method therefor |
| 01/17/2013 | WO2012161489A3 Patch containing rivastigmine |
| 01/17/2013 | WO2012160180A3 Pharmaceutical composition for administration to nails |
| 01/17/2013 | WO2012160179A3 Topical pharmaceutical composition based on semifluorinated alkanes |
| 01/17/2013 | WO2012160051A3 Wet granulation methods of cetyl myristate and/or cetyl palmitate |
| 01/17/2013 | WO2012160050A3 Particle size distribution of cetyl myristate and/or cetyl palmitate |
| 01/17/2013 | WO2012159593A3 A combined oral formulation with controlled release of acetylsalicylic acid and a method for the preparation |
| 01/17/2013 | WO2012159077A3 Multiple dosing regimen oral drug delivery platform |
| 01/17/2013 | WO2012158312A9 Skin and hair regeneration using polysaccharide-based hydrogels |
| 01/17/2013 | WO2012149454A3 Tolerogenic synthetic nanocarriers coupled to cd1d-restricted antigens and methods of use |
| 01/17/2013 | WO2012149376A3 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same |
| 01/17/2013 | WO2012148225A3 Sustained-release pharmaceutical composition comprising donepezil or pharmaceutically acceptable salt thereof having improved dissolution stability and method for manufacturing the same |
| 01/17/2013 | WO2012145428A3 Altering protein concentrations in cerebrospinal fluid and/or brain interstitial fluid |
| 01/17/2013 | WO2012104025A3 Balneotherapeutic lipid-containing probiotic preparations and their applications |
| 01/17/2013 | WO2012103038A3 Nanoparticle compositions, formulations thereof, and uses therefor |
| 01/17/2013 | US20130019348 Pesticidal compositions and processes related thereto |
| 01/17/2013 | US20130018455 Method of inhibiting vascular intimal hyperplasia using stent |
| 01/17/2013 | US20130018431 Method for directed intranasal administration of a composition |
| 01/17/2013 | US20130018299 Nanoshells on polymers |
| 01/17/2013 | US20130018100 Tranexamic Acid Formulations |
| 01/17/2013 | US20130018085 iRNA Agents Targeting VEGF |
| 01/17/2013 | US20130018078 Adhesive mixture for transdermal delivery of highly plasticizing drugs |
| 01/17/2013 | US20130017268 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| 01/17/2013 | US20130017267 Method of making particles for use in a pharmaceutical composition |
| 01/17/2013 | US20130017266 Radiation Therapy Agent |
| 01/17/2013 | US20130017265 Particles for multiple agent delivery |
| 01/17/2013 | US20130017264 Alginate tube drug delivery system and method therefor |
| 01/17/2013 | US20130017263 Gastric acid secretion inhibiting composition |
| 01/17/2013 | US20130017262 Immediate/delayed drug delivery |
| 01/17/2013 | US20130017261 Use of lactobacillus for treatment of virus infections |
| 01/17/2013 | US20130017260 Oral pharmaceutical formulations for the treatment of human canities |
| 01/17/2013 | US20130017259 Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
| 01/17/2013 | US20130017258 Self-microemulsifying mitotane composition |
| 01/17/2013 | US20130017257 Dry powder formulation containing tiotropium for inhalation |
| 01/17/2013 | US20130017256 Methods of treating hypertriglyceridemia |
| 01/17/2013 | US20130017255 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent |
| 01/17/2013 | US20130017254 Pharmaceutical formulation containing phenytoin sodium and magnesium stearate |
| 01/17/2013 | US20130017253 Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions |
| 01/17/2013 | US20130017252 Method for Selectively Inhibiting the Activity of ACAT1 in the Treatment of Alzheimer's Disease |
| 01/17/2013 | US20130017251 Antibody Specific for Apolipoprotein and Methods of Use Thereof |
| 01/17/2013 | US20130017250 Methods For High Density Lipoprotein Cholesterol Regulation |
| 01/17/2013 | US20130017249 COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING siRNA ACTIVITY |
| 01/17/2013 | US20130017248 Cationic Liposomes And Method of Use |
| 01/17/2013 | US20130017247 Treatment and/or prevention of oral allergic symptoms caused by oral contact with fruits and/or vegetables |
| 01/17/2013 | US20130017245 Solid preparation |
| 01/17/2013 | US20130017244 Sustained release intraocular implants and related methods |
| 01/17/2013 | US20130017243 Sustained-release reservoir implants for intracameral drug delivery |
| 01/17/2013 | US20130017239 Lipid nanoparticle capsules |
| 01/17/2013 | US20130017235 Orally administered agent and an orally administered agent/supporting substrate complex |